Literature DB >> 15001639

Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance.

Johan Hoffstedt1, Elisabet Arvidsson, Eva Sjölin, Kerstin Wåhlén, Peter Arner.   

Abstract

The role of adiponectin production for the circulating protein concentration in human obesity and insulin resistance is unclear. We measured serum concentration and sc adipose tissue secretion rate of adiponectin in 77 obese and 23 nonobese women with a varying degree of insulin sensitivity. The serum adiponectin concentration was similar in both groups. In obesity, adiponectin adipose tissue secretion rate per weight unit was reduced by 30% (P = 0.01), whereas total body fat secretion rate was increased by 100% (P < 0.0001). In the group being most insulin resistant (1/3), serum concentration (P < 0.001) and adipose tissue secretion rate per tissue weight (P < 0.05) were reduced, whereas total body fat secretion rate was increased (P < 0.01), by about 30%. The adipose tissue secretion rate of adiponectin was related to the serum concentration (P = 0.005) but explained only about 10% of the interindividual variation in circulating adiponectin and insulin sensitivity. The plasma adiponectin half life was long, 2.5 h. In conclusion, the role of protein secretion for the circulating concentration of adiponectin and insulin sensitivity under these conditions is minor because adiponectin turnover rate is slow. Although increased in obesity and insulin resistance, total body production of adiponectin is insufficient to raise the circulating concentration, may be due to reduced secretion rate per tissue unit.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001639     DOI: 10.1210/jc.2003-031458

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  56 in total

1.  Adenylate kinase 2 links mitochondrial energy metabolism to the induction of the unfolded protein response.

Authors:  Alison Burkart; Xiarong Shi; My Chouinard; Silvia Corvera
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157

2.  Circulating adiponectin levels and risk of endometrial cancer: the prospective Nurses' Health Study.

Authors:  Pamela T Soliman; Xiaohui Cui; Qian Zhang; Susan E Hankinson; Karen H Lu
Journal:  Am J Obstet Gynecol       Date:  2010-11-03       Impact factor: 8.661

3.  A Prospective Analysis of Plasma Adiponectin and Risk of Incident Cancer: The Dallas Heart Study.

Authors:  Muhammad Shaalan Beg; Sadia Saleem; Aslan Turer; Colby Ayers; James A de Lemos; Amit Khera; Philipp E Scherer; Susan G Lakoski
Journal:  J Natl Compr Canc Netw       Date:  2015-07       Impact factor: 11.908

Review 4.  Adiponectin and energy homeostasis.

Authors:  Bonggi Lee; Jianhua Shao
Journal:  Rev Endocr Metab Disord       Date:  2014-06       Impact factor: 6.514

5.  Gene expression of adiponectin and adiponectin receptor 1 in type 2 diabetic rats and the relationship with the parameters of glucose and lipid metabolism.

Authors:  Hui Yao; Hanhua Ling; Hongwei Wang; Longjiang Zhang; Xiaoyan Huang; Zhi Xia
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 6.  Implications of adiponectin in linking metabolism to testicular function.

Authors:  Luc J Martin
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

Review 7.  Adiponectin, driver or passenger on the road to insulin sensitivity?

Authors:  Risheng Ye; Philipp E Scherer
Journal:  Mol Metab       Date:  2013-04-19       Impact factor: 7.422

8.  Globular adiponectin enhances muscle insulin action via microvascular recruitment and increased insulin delivery.

Authors:  Lina Zhao; Weidong Chai; Zhuo Fu; Zhenhua Dong; Kevin W Aylor; Eugene J Barrett; Wenhong Cao; Zhenqi Liu
Journal:  Circ Res       Date:  2013-03-04       Impact factor: 17.367

Review 9.  Adiponectin signaling in the liver.

Authors:  Terry P Combs; Errol B Marliss
Journal:  Rev Endocr Metab Disord       Date:  2014-06       Impact factor: 6.514

10.  A genome-wide association study reveals variants in ARL15 that influence adiponectin levels.

Authors:  J Brent Richards; Dawn Waterworth; Stephen O'Rahilly; Marie-France Hivert; Ruth J F Loos; John R B Perry; Toshiko Tanaka; Nicholas John Timpson; Robert K Semple; Nicole Soranzo; Kijoung Song; Nuno Rocha; Elin Grundberg; Josée Dupuis; Jose C Florez; Claudia Langenberg; Inga Prokopenko; Richa Saxena; Robert Sladek; Yurii Aulchenko; David Evans; Gerard Waeber; Jeanette Erdmann; Mary-Susan Burnett; Naveed Sattar; Joseph Devaney; Christina Willenborg; Aroon Hingorani; Jaquelin C M Witteman; Peter Vollenweider; Beate Glaser; Christian Hengstenberg; Luigi Ferrucci; David Melzer; Klaus Stark; John Deanfield; Janina Winogradow; Martina Grassl; Alistair S Hall; Josephine M Egan; John R Thompson; Sally L Ricketts; Inke R König; Wibke Reinhard; Scott Grundy; H-Erich Wichmann; Phil Barter; Robert Mahley; Y Antero Kesaniemi; Daniel J Rader; Muredach P Reilly; Stephen E Epstein; Alexandre F R Stewart; Cornelia M Van Duijn; Heribert Schunkert; Keith Burling; Panos Deloukas; Tomi Pastinen; Nilesh J Samani; Ruth McPherson; George Davey Smith; Timothy M Frayling; Nicholas J Wareham; James B Meigs; Vincent Mooser; Tim D Spector
Journal:  PLoS Genet       Date:  2009-12-11       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.